Application of umbilical cord mesenchymal stem cells
Umbilical cord mesenchymal stem cells are derived from early-stage embryonic tissues with high differentiation potential and can differentiate in multiple directions. They have broad clinical application prospects in tissue engineering such as bone, cartilage, muscle, tendon, ligament, nerve, liver, endothelium, and myocardium.
Can have strong immune regulatory effects, can be used to treat autoimmune diseases such as lupus erythematosus, reduce immune rejection after cell or organ transplantation, and improve the success rate of cell or organ transplantation;
Can promote hematopoietic recovery function. Compared with single hematopoietic stem cell transplantation, co transplantation of mesenchymal stem cells and hematopoietic stem cells can significantly improve the therapeutic effect of diseases such as leukemia and refractory anemia;
Can repair damaged or diseased tissues and organs, used for the treatment of bone and muscle degenerative diseases, cardiovascular and cerebrovascular diseases, liver disease, brain and spinal cord nerve injuries, and senile dementia.